Carne coltivata: come nasce, l’impatto ambientale e i nuovi traguardi in Europa
Ottanta miliardi di animali: è questo il numero impressionante di esemplari macellati ogni anno nel mondo per il solo consumo alimentare, secondo i dati ufficiali dell’Organizzazione delle Nazioni Unite per l’alimentazione e l’agricoltura (FAO). Un bilancio insostenibile che accelera la crisi innescata dal cambiamento climatico, trainata dall’aumento dei gas serra e dal gravoso impatto ambientale degli […]
Cultivated Meat and the Future of Sustainable Petfood
The growing global population of companion animals, coupled with increasing scrutiny of the environmental impact of food production, has intensified interest in alternative protein sources for pet nutrition. Among the emerging solutions, cultivated meat has great potential because it combines the biological characteristics of conventional animal-derived proteins with the potential to address some of the […]
BeneMeat opens its doors to Czech meat processors as cultivated meat dialog gains momentum
BeneMeat has hosted representatives from the Czech Meat Processors Association (ČSZM) at its pilot production facility, as the cultivated meat company sought to strengthen ties with the conventional meat industry through what it described as an open, fact-based dialog.
BeneMeat empfängt tschechischen Fleischindustrieverband ČSZM in seiner Pilotanlage
Das tschechische Biotech-Unternehmen BeneMeat hat eine Delegation des tschechischen Verbandes der Fleischverarbeiter (ČSZM) in seiner Pilotproduktionsanlage empfangen und den Besuch genutzt, um die Zellkulturtechnologie als Ergänzung zu den Produktpaletten herkömmlicher Verarbeiter und nicht als Ersatz dafür zu positionieren.
BeneMeat Chooses Dialogue Over Competition with Traditional Meat Sector
Czech cultivated meat developer Benemeat is signalling a different strategy. Rather than treating the traditional meat sector as the competition, the company has publicly invited representatives from across the conventional meat industry into direct dialogue, arguing that prejudice and misinformation will not solve the protein challenges facing future food systems.
Dialogue instead of prejudice: BeneMeat welcomes representatives of the Czech Meat Processors Association
Open dialogue is the foundation of every technological transformation. With this objective in mind, BeneMeat welcomed representatives of the Czech Meat Processors Association (ČSZM) to showcase its pilot production facility and cultivated meat manufacturing technology. The meeting confirmed a shared commitment to fact-based discussion, mutual understanding, and exploring future opportunities.
BeneMeat Opens Pilot Plant to Czech Meat Industry Body in Bid to Frame Cultivated Cells as a Complement, Not a Rival
Czech biotech company BeneMeat has hosted a delegation from the Czech Meat Processors Association (ČSZM) at its pilot production facility, using the visit to position cultivated cell technology as an addition to conventional processors’ product lines rather than a substitute for them.
BeneMeat Opens Pilot Plant to Czech Meat Industry Body in Bid to Frame Cultivated Cells as a Complement, Not a Rival
Czech biotech company BeneMeat has hosted a delegation from the Czech Meat Processors Association (ČSZM) at its pilot production facility, using the visit to position cultivated cell technology as an addition to conventional processors’ product lines rather than a substitute for them.
Dialogue Instead of Division as Benemeat Opens the Door to Traditional Meat Industry
Czech cultivated meat developer Benemeat is signalling a different strategy. Rather than treating the traditional meat sector as the competition, the company has publicly invited representatives from across the conventional meat industry into direct dialogue, arguing that prejudice and misinformation will not solve the protein challenges facing future food systems. While details of the meeting focus […]
Europa chce odzyskać pozycję lidera biotechnologii. Biotech Act II dopiero zaczyna nabierać kształtu
Kiedy 16 grudnia 2025 roku Komisja Europejska przedstawiła propozycję pierwszego Europejskiego Aktu Biotechnologicznego, nikt nie miał wątpliwości, że to dopiero pierwszy krok. Biotech Act I, skoncentrowany na biotechnologii zdrowotnej, miał za zadanie wzmocnić konkurencyjność sektora, uprościć procesy regulacyjne i przyspieszyć wprowadzanie innowacji na rynek, przy jednoczesnym zachowaniu wysokich standardów bezpieczeństwa, etyki i zrównoważonego rozwoju. Jednak już w […]
